Delivering experienced investigators, a diverse West Valley patient base, and efficient trial execution in Glendale, Arizona.
Delivering experienced investigators, a diverse West Valley patient base, and efficient trial execution in Glendale, Arizona.
Sun City Clinical Research is a dedicated Phase II through IV clinical research site in Glendale, Arizona, embedded within a multi-specialty practice serving a broad patient base across the greater Phoenix West Valley region. With three board-certified investigators spanning cardiology, endocrinology, and obstetrics and gynecology, our site offers sponsors and CROs a reliable clinical research center in Glendale AZ backed by an extensive research candidate database.
As a proud member of ECN Clinical, Sun City Clinical Research operates under centralized SOPs, unified contracting, and network-wide quality standards, giving sponsors and CROs the consistency of a national network with the accountability of a dedicated local site.
Sun City Clinical Research conducts clinical research across six therapeutic areas led by board-certified principal investigator Dr. Kishlay Anand. The site brings specialized expertise in pulmonology clinical research Glendale AZ, cardiology clinical research Glendale AZ, and dermatology clinical research Glendale AZ, alongside vaccine clinical research Glendale AZ, endocrinology clinical research Glendale AZ, and gastroenterology clinical research Glendale AZ.
Our patient recruitment infrastructure combines technology, community relationships, and dedicated outreach to deliver consistent enrollment performance across every study we support.
Sun City Clinical Research serves a diverse adult patient population across Glendale and the greater Phoenix West Valley region in Arizona. Our location at 11851 N 51st Ave gives participants throughout the Glendale area a convenient research site, supported by complementary community outreach programs, flexible scheduling, transportation assistance, and a patient-first care model throughout every study.
Our Glendale location gives Sun City Clinical Research access to one of Arizona's most diverse and rapidly growing communities in the Phoenix West Valley. With a patient population that is 38% non-white, our bilingual English and Spanish team ensures every participant is fully informed and supported throughout their study journey.
Diversity in clinical research is a commitment to the communities we serve. Our sites are chosen and structured to reflect the communities they serve, ensuring every study benefits from genuine local representation, trust, and accessibility.
Our network capability deck or TA-specific one-pagers to share with your team.
Yes. Sun City Clinical Research offers paid clinical research opportunities in Glendale AZ and across the greater Phoenix and Arizona region. Compensation varies by study and will be explained clearly before you enroll. Study-related medical care and visits are always at no cost to participants.
Sun City Clinical Research is a dedicated clinical research center in Glendale AZ located at 11851 N 51st Ave, Building G, Glendale, Arizona 85304, serving participants across a 40-mile catchment radius throughout the greater Phoenix West Valley region.
Sun City Clinical Research is a CLIA-certified clinical research site in Glendale AZ offering Phase II through IV capabilities. Our site features onsite ECG, cold chain and temperature-controlled drug storage, DEA license, CTMS and multiple EDC platforms, eConsent, Florence eISF for remote monitoring, and specialty procedures including biopsies, infusion, PK sampling, spirometry, oscillometry, FeNO, and certified FibroScan.
Sun City Clinical Research conducts pulmonology clinical research, cardiology clinical research, dermatology clinical research, vaccine clinical research, endocrinology clinical research, and gastroenterology clinical research in Glendale AZ, led by board-certified principal investigator Dr. Kishlay Anand.
Yes. Sun City Clinical Research is a dedicated clinical research site for sponsors and CROs, operating as part of the ECN Clinical under centralized SOPs, unified contracting, and network-wide quality standards. Sponsors and CROs benefit from a proven 85% screen to enroll rate, 91% patient retention rate, and startup timelines consistently under four weeks.
